Stockreport

Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting

Kodiak Sciences Inc  (KOD) 
Last kodiak sciences inc earnings: 11/12 05:30 am Check Earnings Report
PDF PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to tr [Read more]